STOCK TITAN

Preaxia Health Care Pmt Sys In Financials

PAXH
Source SEC Filings (10-K/10-Q) Updated Aug 31, 2025 Currency USD FYE May

This page shows Preaxia Health Care Pmt Sys In (PAXH) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 17 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Financial Health Signals

Earnings Quality Low Quality
0.51x

For every $1 of reported earnings, Preaxia Health Care Pmt Sys In generates $0.51 in operating cash flow (-$42K OCF vs -$82K net income). This low ratio suggests earnings are primarily driven by accounting accruals rather than cash generation, which may not be sustainable.

Key Financial Metrics

Export CSV
Revenue
$0

Preaxia Health Care Pmt Sys In generated $0 in revenue in fiscal year 2025.

EBITDA
N/A
Free Cash Flow
N/A
Net Income
-$82K
YoY+17.5%

Preaxia Health Care Pmt Sys In reported -$82K in net income in fiscal year 2025. This represents an increase of 17.5% from the prior year.

EPS (Diluted)
$-0.00
YoY+92.0%

Preaxia Health Care Pmt Sys In earned $-0.00 per diluted share (EPS) in fiscal year 2025. This represents an increase of 92.0% from the prior year.

Cash & Debt
$0
YoY-100.0%

Preaxia Health Care Pmt Sys In held $0 in cash against $0 in long-term debt as of fiscal year 2025.

Dividends Per Share
N/A
Shares Outstanding
20M
YoY+0.0%
5Y CAGR+0.0%

Preaxia Health Care Pmt Sys In had 20M shares outstanding in fiscal year 2025. This represents an increase of 0.0% from the prior year.

Gross Margin
N/A
Operating Margin
N/A
Net Margin
N/A
Return on Equity
N/A
R&D Spending
$0
YoY-100.0%

Preaxia Health Care Pmt Sys In invested $0 in research and development in fiscal year 2025. This represents a decrease of 100.0% from the prior year.

Share Buybacks
N/A
Capital Expenditures
N/A

PAXH Income Statement

Metric Q1'26 Q3'25 Q2'25 Q2'24 Q1'25 Q2'23 Q3'24 Q1'24
Revenue $0 $0 $0 $0 $0-100.0% $230 $0 $0
Cost of Revenue N/A N/A N/A N/A $0 N/A N/A $0
Gross Profit N/A N/A N/A N/A $0 N/A N/A $0
R&D Expenses $391K $0 $0-100.0% $2K+3.5% $2K-26.7% $2K+458.8% $371-88.7% $3K
SG&A Expenses $8K+81.4% $5K+228.4% $1K-78.7% $6K+284.5% $2K-77.6% $8K+180.7% $3K+70.0% $2K
Operating Income -$875K-9834.2% -$9K+35.5% -$14K+69.7% -$45K-10.2% -$41K+6.3% -$44K-19.6% -$36K+2.3% -$37K
Interest Expense -$69 N/A N/A N/A N/A N/A N/A N/A
Income Tax $0 $0 N/A N/A N/A N/A N/A N/A
Net Income -$875K-6400.3% -$13K+1.5% -$14K+69.7% -$45K-10.2% -$41K+6.3% -$44K-19.6% -$36K+2.3% -$37K
EPS (Diluted) $-0.04 $0.00 $0.00 $0.00 $0.00 N/A $0.00 $0.00

PAXH Balance Sheet

Metric Q1'26 Q3'25 Q2'25 Q2'24 Q1'25 Q2'23 Q3'24 Q1'24
Total Assets $1.2M+38342733.3% $3-98.2% $165+1078.6% $14-96.1% $355+5816.7% $6-81.3% $32-84.0% $200
Current Assets $490K+16342733.3% $3-98.2% $165+1078.6% $14-96.1% $355+5816.7% $6-81.3% $32-84.0% $200
Cash & Equivalents $130K+4342733.3% $3-98.2% $165+1078.6% $14-96.1% $355+5816.7% $6-81.3% $32-84.0% $200
Inventory N/A N/A N/A N/A N/A N/A N/A N/A
Accounts Receivable N/A N/A N/A N/A N/A N/A N/A N/A
Goodwill N/A N/A N/A N/A N/A N/A N/A N/A
Total Liabilities $723K-70.2% $2.4M+0.6% $2.4M+0.8% $2.4M+2.5% $2.3M+1.8% $2.3M+1.7% $2.3M+3.7% $2.2M
Current Liabilities $723K-70.2% $2.4M+0.6% $2.4M+0.8% $2.4M+2.5% $2.3M+1.8% $2.3M+1.7% $2.3M+3.7% $2.2M
Long-Term Debt N/A N/A N/A N/A N/A N/A N/A N/A
Total Equity $427K+117.6% -$2.4M-0.6% -$2.4M-0.8% -$2.4M-2.5% -$2.3M-1.8% -$2.3M-1.7% -$2.3M-3.7% -$2.2M
Retained Earnings -$6.1M-17.9% -$5.2M-0.3% -$5.1M-0.4% -$5.1M-1.2% -$5.1M-0.8% -$5.0M-0.7% -$5.0M-1.7% -$4.9M

PAXH Cash Flow Statement

Metric Q1'26 Q3'25 Q2'25 Q2'24 Q1'25 Q2'23 Q3'24 Q1'24
Operating Cash Flow -$75K-46073.5% -$162-105.5% $3K+121.3% -$14K-1.6% -$14K-140.2% -$6K+28.7% -$8K+40.2% -$13K
Capital Expenditures N/A N/A N/A N/A N/A N/A N/A N/A
Free Cash Flow N/A N/A N/A N/A N/A N/A N/A N/A
Investing Cash Flow $0 $0 $0 $0 $0 $0 $0 $0
Financing Cash Flow $205K $0+100.0% -$3K-122.0% $13K-9.4% $14K+147.5% $6K-27.8% $8K-41.0% $13K
Dividends Paid N/A N/A N/A N/A N/A N/A N/A N/A
Share Buybacks N/A N/A N/A N/A N/A N/A N/A N/A

PAXH Financial Ratios

Metric Q1'26 Q3'25 Q2'25 Q2'24 Q1'25 Q2'23 Q3'24 Q1'24
Gross Margin N/A N/A N/A N/A N/A N/A N/A N/A
Operating Margin N/A N/A N/A N/A N/A -18980.4% N/A N/A
Net Margin N/A N/A N/A N/A N/A -18980.4% N/A N/A
Return on Equity N/A N/A N/A N/A N/A N/A N/A N/A
Return on Assets -76.1%+448690.6pp -448766.7%-440484.3pp -8282.4%+17484.4pp -25766.9%-14240.4pp -11526.5%+28159.9pp -39686.4%+74338.6pp -114025.0%-95351.5pp -18673.5%
Current Ratio 0.68+0.7 0.000.0 0.000.0 0.000.0 0.000.0 0.000.0 0.000.0 0.00
Debt-to-Equity 1.69+2.7 -1.000.0 -1.000.0 -1.000.0 -1.000.0 -1.000.0 -1.000.0 -1.00
FCF Margin N/A N/A N/A N/A N/A N/A N/A N/A

Note: Shareholder equity is negative (-$2.3M), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.

Note: The current ratio is below 1.0 (0.00), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.

Frequently Asked Questions

What is Preaxia Health Care Pmt Sys In's annual revenue?

Preaxia Health Care Pmt Sys In (PAXH) reported $0 in total revenue for fiscal year 2025. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

Is Preaxia Health Care Pmt Sys In profitable?

No, Preaxia Health Care Pmt Sys In (PAXH) reported a net income of -$82K in fiscal year 2025.

What is Preaxia Health Care Pmt Sys In's earnings per share (EPS)?

Preaxia Health Care Pmt Sys In (PAXH) reported diluted earnings per share of $-0.00 for fiscal year 2025. This represents a 92.0% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

What is Preaxia Health Care Pmt Sys In's operating cash flow?

Preaxia Health Care Pmt Sys In (PAXH) generated -$42K in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are Preaxia Health Care Pmt Sys In's total assets?

Preaxia Health Care Pmt Sys In (PAXH) had $0 in total assets as of fiscal year 2025, including both current and long-term assets.

How many shares does Preaxia Health Care Pmt Sys In have outstanding?

Preaxia Health Care Pmt Sys In (PAXH) had 20M shares outstanding as of fiscal year 2025.

What is Preaxia Health Care Pmt Sys In's current ratio?

Preaxia Health Care Pmt Sys In (PAXH) had a current ratio of 0.00 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.

What is Preaxia Health Care Pmt Sys In's debt-to-equity ratio?

Preaxia Health Care Pmt Sys In (PAXH) had a debt-to-equity ratio of -1.00 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Preaxia Health Care Pmt Sys In's cash runway?

Based on fiscal year 2025 data, Preaxia Health Care Pmt Sys In (PAXH) had $0 in cash against an annual operating cash burn of $42K. This gives an estimated cash runway of approximately 0 months at the current burn rate. Cash runway measures how long a company can continue operating before running out of cash, assuming no additional funding.

Why is Preaxia Health Care Pmt Sys In's debt-to-equity ratio negative or unusual?

Preaxia Health Care Pmt Sys In (PAXH) has negative shareholder equity of -$2.3M as of fiscal year 2025, which causes the debt-to-equity ratio to appear negative or not meaningful. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.

Are Preaxia Health Care Pmt Sys In's earnings high quality?

Preaxia Health Care Pmt Sys In (PAXH) has an earnings quality ratio of 0.51x, considered low quality (accrual-driven). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.